These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Amidic modification of valproic acid reduces skeletal teratogenicity in mice. Okada A, Kurihara H, Aoki Y, Bialer M, Fujiwara M. Birth Defects Res B Dev Reprod Toxicol; 2004 Feb; 71(1):47-53. PubMed ID: 14991910 [Abstract] [Full Text] [Related]
3. Tetramethylcyclopropyl analogue of the leading antiepileptic drug, valproic acid: evaluation of the teratogenic effects of its amide derivatives in NMRI mice. Okada A, Onishi Y, Yagen B, Shimshoni JA, Kaufmann D, Bialer M, Fujiwara M. Birth Defects Res A Clin Mol Teratol; 2008 Sep; 82(9):610-21. PubMed ID: 18671279 [Abstract] [Full Text] [Related]
4. Polycomb homologs are involved in teratogenicity of valproic acid in mice. Okada A, Aoki Y, Kushima K, Kurihara H, Bialer M, Fujiwara M. Birth Defects Res A Clin Mol Teratol; 2004 Nov; 70(11):870-9. PubMed ID: 15523661 [Abstract] [Full Text] [Related]
5. Anticonvulsant profile and teratogenic evaluation of potent new analogues of a valproic acid urea derivative in NMRI mice. Okada A, Noyori H, Yagen B, Shimshoni JA, Bialer M, Fujiwara M. Birth Defects Res B Dev Reprod Toxicol; 2009 Oct; 86(5):394-401. PubMed ID: 19830722 [Abstract] [Full Text] [Related]
6. Valnoctamide, valpromide and valnoctic acid are much less teratogenic in mice than valproic acid. Radatz M, Ehlers K, Yagen B, Bialer M, Nau H. Epilepsy Res; 1998 Mar; 30(1):41-8. PubMed ID: 9551843 [Abstract] [Full Text] [Related]
8. Pharmacologic evaluation of various metabolites and analogs of valproic acid: teratogenic potencies in mice. Nau H, Löscher W. Fundam Appl Toxicol; 1986 May; 6(4):669-76. PubMed ID: 3086174 [Abstract] [Full Text] [Related]
9. Stereoselective anticonvulsant and pharmacokinetic analysis of valnoctamide, a CNS-active derivative of valproic acid with low teratogenic potential. Shekh-Ahmad T, Hen N, Yagen B, McDonough JH, Finnell RH, Wlodarczyk BJ, Bialer M. Epilepsia; 2014 Feb; 55(2):353-61. PubMed ID: 24313671 [Abstract] [Full Text] [Related]
10. Myo-inositol enhances teratogenicity of valproic acid in the mouse. Massa V, Wlodarczyk B, Giavini E, Finnell RH. Birth Defects Res A Clin Mol Teratol; 2006 Mar; 76(3):200-4. PubMed ID: 16511884 [Abstract] [Full Text] [Related]
12. Teratogenicity of valproate conjugates with anticonvulsant activity in mice. Spiegelstein O, Chatterjie N, Alexander G, Finnell RH. Epilepsy Res; 2003 Dec; 57(2-3):145-52. PubMed ID: 15013055 [Abstract] [Full Text] [Related]
13. Anti-epileptic activity, toxicity and teratogenicity in CD1 mice of a novel valproic acid arylamide derivative, N-(2-hydroxyphenyl)-2-propylpentanamide. Cristóbal-Luna JM, Correa-Basurto J, Mendoza-Figueroa HL, Chamorro-Cevallos G. Toxicol Appl Pharmacol; 2020 Jul 15; 399():115033. PubMed ID: 32387339 [Abstract] [Full Text] [Related]
14. Inhibition of nitric oxide synthesis enhances teratogenic effects induced by valproic Acid. Tiboni GM, Chiarelli F, Verrotti A. In Vivo; 2013 Jul 15; 27(4):513-8. PubMed ID: 23812222 [Abstract] [Full Text] [Related]
15. Short-time gene expression response to valproic acid and valproic acid analogs in mouse embryonic stem cells. Jergil M, Forsberg M, Salter H, Stockling K, Gustafson AL, Dencker L, Stigson M. Toxicol Sci; 2011 Jun 15; 121(2):328-42. PubMed ID: 21427059 [Abstract] [Full Text] [Related]
17. Teratology study of derivatives of tetramethylcyclopropyl amide analogues of valproic acid in mice. Okada A, Onishi Y, Aoki Y, Yagen B, Sobol E, Bialer M, Fujiwara M. Birth Defects Res B Dev Reprod Toxicol; 2006 Jun 15; 77(3):227-33. PubMed ID: 16767757 [Abstract] [Full Text] [Related]